Skip to main content
. 2018 Mar 21;14(6):1370–1377. doi: 10.1080/21645515.2018.1442162

Figure 5.

Figure 5.

Prediction models for frequency of gE-specific CD4[2+] T cells 72 months vs 108 months (Subjects who received two doses of HZ/su VZV vaccine). Panel A: Piece-wise linear; Panel B: Power-law, Panel C: Fraser.